Tesamorelin + Ipamorelin Blend Pre-Research Checklist

Before a wholesale buyer stocks a tesamorelin and ipamorelin blend, five things need to be verified in order: a batch-specific certificate of analysis you can open yourself without asking a sales rep; identity and purity data that resolves each peptide separately rather than reporting one combined number; a label that states the mass of each component and the total peptide mass per vial; tier pricing, minimum order quantities, and lead times supplied in writing before you commit; and documented domestic fulfillment with defined cold-chain handling. Everything discussed here concerns compounds supplied for laboratory research use only. They are not for human consumption, and nothing below is dosing, preparation, or administration guidance.

Why co-formulated vials raise the diligence bar

A single-compound vial gives you one analyte to verify. A blend gives you two, plus the interaction between them, plus a ratio that only the manufacturer knows unless the paperwork proves it. That is three additional failure points, and most of them are invisible on a label.

Tesamorelin is a growth hormone-releasing hormone analog; research literature describes it as acting on GHRH receptors in the pituitary. Ipamorelin is a selective growth hormone secretagogue studied for its activity at the ghrelin receptor. Studies indicate the two act through distinct receptor pathways, which is why co-formulated presentations appear in research catalogs at all. That is the extent of the scientific claim worth making in a buyer-facing context — the compounds are research materials, and their behavior in any model system is the researcher's question to answer, not the distributor's to promise.

What matters commercially is that the two peptides differ meaningfully in molecular size, sequence length, and chromatographic behavior. That difference is exactly what makes a lazy analytical report dangerous. A chromatogram run under conditions optimized for one peptide can under-resolve the other, and a purity figure reported as a single percentage for the vial tells you almost nothing about whether the second component is present at the stated mass, degraded, or short.

Real Peptides lists Tesamorelin 10mg and Ipamorelin 10mg as separate catalog items. If you are evaluating a co-formulated presentation from any supplier, the checklist below is the diligence that separates a defensible sourcing decision from a guess.

The paperwork to have in hand before the first purchase order

Documentation is the cheapest part of diligence and the part suppliers most often make expensive. Some programs release a certificate of analysis only after a sale. Some charge for it. Some post a single generic COA that covers every batch ever produced, which is a contradiction in terms — a certificate that does not name a lot number certifies nothing.

Here is what to collect, and what should end the conversation:

If a supplier cannot produce a lot-linked COA before you place an order, you are not buying a verified product — you are buying a claim. That distinction matters more on a blend than anywhere else in the catalog, because there is no way to eyeball a ratio.

Reading purity data when two peptides share a vial

Ask the supplier one question and listen carefully to the answer: was purity determined for each component independently?

On a co-formulation, a reported purity figure can be constructed in several ways. It can describe total peptide content against non-peptide impurities. It can describe the largest single peak. It can describe each sequence separately. Those are three different numbers, and only the third tells a buyer what is in the vial. A 99%+ HPLC purity figure is meaningful when the method and the analyte are both named; it is decorative when neither is.

Second question: does the analytical record include identity confirmation, not just purity? Purity tells you how much of the sample is the intended material. Identity tells you whether the intended material is what the label says. A batch can be extremely pure and still be the wrong sequence, a truncated sequence, or a diastereomer. On a blend, an identity failure on the minor component is the hardest thing in the world to notice downstream.

Third question: who ran the test? Third-party analysis carries more weight than an in-house report, and a supplier that publishes testing openly is making a different bet than one that keeps results behind a login. The practical test is simple — can you, right now, without an account, look at the lab results for a specific lot? If yes, the supplier has accepted the cost of being checked. If no, ask why.

Ratio, mass, and label questions that drive your inventory math

For a blended presentation, the label needs to answer three questions without ambiguity: how many milligrams of each peptide are in the vial, what the total peptide mass is, and what ratio those figures represent. Suppliers sometimes state only a combined total, which leaves the buyer unable to compare one supplier's blend against another's on any consistent basis.

This is also where preparation questions tend to arrive, and it is worth being direct about the boundary. Real Peptides does not publish reconstitution, preparation, or dosing guidance for any catalog item, because these are research-use-only compounds and those decisions belong to the qualified researcher operating under their own protocols and institutional oversight. What a buyer is entitled to understand is the concentration framework: total milligrams of each peptide per vial, expressed against a stated solvent volume as milligrams per milliliter. That framework is how you compare products, price out a tier, and document what you are stocking. It is also where supplier-provided guidance stops.

For inventory planning, also confirm the presentation format, the stated storage condition for the lyophilized material, and whether the supplier's shipping method preserves that condition through transit. Ask what happens if a shipment arrives outside spec — a supplier with a real answer has thought about it before.

Commercial terms worth pinning down before you commit volume

The research peptide wholesale market still contains a lot of opacity, and blends are where opacity is most profitable for the seller. Three practices are worth screening for.

Hidden pricing is the first. If tier breaks and minimum order quantities are not available in writing before you apply, you cannot model a catalog decision — you can only react to whatever number arrives. Margins in this category vary widely with volume, compound, and presentation, and any supplier quoting you a universal margin figure is selling a story rather than a price list.

Paid or gated COAs are the second. Charging for analytical documentation inverts the relationship: testing exists to give the buyer confidence, and confidence sold separately is not confidence.

Unverifiable testing claims are the third, and the most common. "Third-party tested" with no lab named, no method stated, and no retrievable report is a phrase, not a control. The fix is not to trust harder; it is to ask for the lot number and the document.

Also settle the operational basics: where orders ship from, what fulfillment timeline the supplier commits to, how reorders are processed, whether account pricing persists between orders, and who you contact when a batch question arises. These are unglamorous and they determine whether a supplier relationship survives its first problem.

What Real Peptides does differently

Real Peptides operates on the premise that a wholesale buyer should be able to verify claims rather than accept them.

Every batch is tested to a 99%+ HPLC purity standard, and testing runs as a seven-panel batch protocol rather than a single purity check. Certificates of analysis are publicly verifiable — a buyer, or a buyer's customer, can look up the lab results for a lot directly rather than requesting them from a sales contact or paying for access. Orders fulfill from within the United States on a 5–7 day timeline, which removes the customs variability that makes overseas sourcing hard to plan around.

The Wholesale Partner Program runs on a three-step application: submit the business application, complete verification, and receive tier pricing. Pricing structure and minimum order quantities are provided as part of that process rather than negotiated in the dark, and the catalog is organized so buyers can evaluate a category rather than a single SKU — including the growth factor and tissue signaling research compounds that sit alongside secretagogue research materials.

All compounds are supplied for laboratory research use only. They are not FDA-approved drugs, are not sold for human consumption, and Real Peptides does not provide preparation or dosing guidance for any of them.

Regulatory questions that belong with your attorney

This section is informational and is not legal advice. Whether your business may purchase, hold, relabel, or resell research-use-only compounds depends on your entity type, your licensure, and rules that vary by jurisdiction and change over time.

The productive move is to arrive at counsel with questions rather than assumptions. Ask: does our license class permit holding research materials, and under what recordkeeping obligations? What does our state board say about resale versus internal research use? What labeling and record requirements attach to materials we redistribute? What restrictions apply to how we describe these compounds in our own marketing? And what documentation would we need to produce if asked?

No supplier — including Real Peptides — can answer those questions for your business. A supplier's job is to make the underlying facts about the material verifiable so that your attorney and your state board have something factual to work with. Treat any vendor that offers you a legal conclusion as a vendor that has told you something about its judgment.

Putting the checklist to work

If you have worked through the documentation, analytical, labeling, and commercial questions above and want to see how a supplier answers them in practice, the Wholesale Partner Program application is the next step — submit your business details, complete verification, and receive tier pricing with the analytical documentation attached rather than withheld.

Buyers evaluating adjacent research categories can review individual catalog items such as CJC-1295 No DAC 10mg, BPC-157 10mg, and TB-500 10mg, or browse the broader popular peptides and performance and recovery research collections to see how purity documentation is presented across the catalog.